(Q78595329)

English

Oncolytic viruses

scientific article published on 01 December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

Europe PubMed Central

Oncolytic viruses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

oncolytic virus

1 reference

based on heuristic

inferred from title

author name string

E Antonio Chiocca

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Nature Reviews Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

938-950

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12459732%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

https://scigraph.springernature.com/pub.10.1038/nrc948

0 references

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Treatment of human cancer with mumps virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

OBSERVATIONS ON THE REPEATED ADMINISTRATION OF VIRUSES TO A PATIENT WITH ACUTE LEUKEMIA. A PRELIMINARY REPORT.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

ONYX-015 selectivity and the p14ARF pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Binding and modulation of p53 by p300/CBP coactivators

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Virus-mediated killing of cells that lack p53 activity

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

PKR; a sentinel kinase for cellular stress

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Ribonucleotide reductase: regulation, regulation, regulation

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Intergeneric poliovirus recombinants for the treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Mechanism of activation of early viral transcription by the adenovirus E1A gene product

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

DNA replication of first-generation adenovirus vectors in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Regression of Burkitt's lymphoma in association with measles infection.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Phase II study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The complement response against an oncolytic virus is species-specific in its activation pathways

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The effect of ganciclovir on herpes simplex virus-mediated oncolysis

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Quantitation of HSV mass distribution in a rodent brain tumor model.

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Bioluminescent indicators in living mammals

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Reovirus as an oncolytic agent against experimental human malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Reovirus oncolysis of human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Regulation of herpes simplex virus 1 replication using tumor-associated promoters

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

31 March 2020

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNRC948

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78595329&oldid=2047552900"